These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

26 related articles for article (PubMed ID: 14213747)

  • 1. [Avoidable mistakes in antitubercular chemotherapy].
    Radenbach KL
    Beitr Klin Erforsch Tuberk Lungenkr; 1969; 140(1):128-41. PubMed ID: 5824360
    [No Abstract]   [Full Text] [Related]  

  • 2. A comparison of rifampicin, ethambutol or PAS in short-term monotherapy in pretreated cavitary pulmonary tuberculosis.
    Pneumonologie; 1975 Dec; 153(1):43-59. PubMed ID: 1105471
    [No Abstract]   [Full Text] [Related]  

  • 3. THE INCIDENCE OF VIABLE TUBERCLE BACILLI IN TUBERCULOUS LESIONS FOLLOWING CHEMOTHERAPY: COMPARISON OF TWO CULTURE TECHNIQUES.
    KAZLOWSKI JP; RALEIGH JW; STEENKEN W
    Tubercle; 1964 Jun; 45():101-5. PubMed ID: 14161907
    [No Abstract]   [Full Text] [Related]  

  • 4. [ON THE BACTERIAL SENSITIVITY TO ANTIBACTERIAL AGENTS IN PULMONARY TUBERCULOSIS. I. ON THE BACTERIAL TESTS].
    MACHADO J; WOLOSKER N
    Rev Bras Tuberc Doencas Torac; 1963 Jun; 31():7-26. PubMed ID: 14049203
    [No Abstract]   [Full Text] [Related]  

  • 5. [BACILLI COUNT--A DIRECTIVE FOR TUBERCULOSTATIC THERAPY].
    SERI I
    Beitr Klin Tuberk Spezif Tuberkuloseforsch; 1964 Feb; 128():50-62. PubMed ID: 14152182
    [No Abstract]   [Full Text] [Related]  

  • 6. RECOVERABILITY OF ACID-FAST BACILLI FROM RESECTED PULMONARY TUBERCULOUS LESIONS AS RELATED TO THE DURATION OF PREOPERATIVE ANTITUBERCULOUS DRUG THERAPY.
    KILLEN DA; FOSTER JH; RHEA WG; MCCRACKEN RC; DIVELEY WL; HUBBARD WW
    J Thorac Cardiovasc Surg; 1964 May; 47():610-5. PubMed ID: 14159052
    [No Abstract]   [Full Text] [Related]  

  • 7. AN INTERESTING MICROORGANISM RECOVERED FROM THREE PATIENTS WITH SYSTEMIC DISEASE.
    LOURIA DB; ALTURE WERBER E; O'HARE D
    Am Rev Respir Dis; 1964 Sep; 90():437-47. PubMed ID: 14215912
    [No Abstract]   [Full Text] [Related]  

  • 8. [THE EXCRETION OF VISIBLE, BUT NON-VIABLE TUBERCLE BACTERIA DURING CHEMOTHERAPY OF CAVERNOUS PULMONARY TUBERCULOSIS].
    BARTMANN K; SCHUETZ I; VIETINGHOFF-SCHEEL OE
    Prax Pneumol; 1964 May; 18():273-87. PubMed ID: 14213747
    [No Abstract]   [Full Text] [Related]  

  • 9. [Tuberculosis of respiratory organs: diagnosis and chemotherapy].
    Mishin VIu; Borisov SE; Aksenova VA; Vasil'ev IA; Dorozhkova IR; Safonova SG; Sidorova SV
    Probl Tuberk Bolezn Legk; 2005; (3):47-64. PubMed ID: 15945454
    [No Abstract]   [Full Text] [Related]  

  • 10. The impact of chemotherapy on the care of patients with tuberculosis.
    Johnston RF; Wildrick KH
    Am Rev Respir Dis; 1974 Jun; 109(6):636-64. PubMed ID: 4209115
    [No Abstract]   [Full Text] [Related]  

  • 11. [Bacteriology of tuberculosis].
    Pneumologie; 1991 Oct; 45 Suppl 3():753-73. PubMed ID: 1771168
    [No Abstract]   [Full Text] [Related]  

  • 12. Current concepts of epidemiology, diagnosis and treatment of childhood tuberculosis in the United States.
    Starke JR
    Indian Pediatr; 1991 Apr; 28(4):335-55. PubMed ID: 1752651
    [No Abstract]   [Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.